170 results on '"Jessica Wagner"'
Search Results
2. Discovery of immunotherapy targets for pediatric solid and brain tumors by exon-level expression
- Author
-
Timothy I. Shaw, Jessica Wagner, Liqing Tian, Elizabeth Wickman, Suresh Poudel, Jian Wang, Robin Paul, Selene C. Koo, Meifen Lu, Heather Sheppard, Yiping Fan, Francis H. O’Neill, Ching C. Lau, Xin Zhou, Jinghui Zhang, and Stephen Gottschalk
- Subjects
Science - Abstract
Abstract Immunotherapy with chimeric antigen receptor T cells for pediatric solid and brain tumors is constrained by available targetable antigens. Cancer-specific exons present a promising reservoir of targets; however, these have not been explored and validated systematically in a pan-cancer fashion. To identify cancer specific exon targets, here we analyze 1532 RNA-seq datasets from 16 types of pediatric solid and brain tumors for comparison with normal tissues using a newly developed workflow. We find 2933 exons in 157 genes encoding proteins of the surfaceome or matrisome with high cancer specificity either at the gene (n = 148) or the alternatively spliced isoform (n = 9) level. Expression of selected alternatively spliced targets, including the EDB domain of fibronectin 1, and gene targets, such as COL11A1, are validated in pediatric patient derived xenograft tumors. We generate T cells expressing chimeric antigen receptors specific for the EDB domain or COL11A1 and demonstrate that these have antitumor activity. The full target list, explorable via an interactive web portal ( https://cseminer.stjude.org/ ), provides a rich resource for developing immunotherapy of pediatric solid and brain tumors using gene or AS targets with high expression specificity in cancer.
- Published
- 2024
- Full Text
- View/download PDF
3. Correction: Desires for Individual- and Interpersonal-Level Patient Portal Use for HIV Prevention Among Urban Sexual Minority Men: Cross-sectional Study
- Author
-
Kevon-Mark P Jackman, Carla Tilchin, Jessica Wagner, Ryan E Flinn, Maria Trent, Carl Latkin, Sebastian Ruhs, Errol L Fields, Matthew M Hamill, Carlos Mahaffey, Adena Greenbaum, and Jacky M Jennings
- Subjects
Medicine - Published
- 2023
- Full Text
- View/download PDF
4. Desires for Individual- and Interpersonal-Level Patient Portal Use for HIV Prevention Among Urban Sexual Minority Men: Cross-sectional Study
- Author
-
Kevon-Mark P Jackman, Carla Tilchin, Jessica Wagner, Ryan E Flinn, Maria Trent, Carl Latkin, Sebastian Ruhs, Errol L Fields, Matthew M Hamill, Carlos Mahaffey, Adena Greenbaum, and Jacky M Jennings
- Subjects
Medicine - Abstract
BackgroundGay, bisexual, and other sexual minority men have expressed the acceptability of patient portals as tools for supporting HIV prevention behaviors, including facilitating disclosure of HIV and other sexually transmitted infection (STI/HIV) laboratory test results to sex partners. However, these studies, in which Black or African American sexual minority men were undersampled, failed to determine the relationship of reported history of discussing HIV results with sex partners and anticipated willingness to disclose web-based STI/HIV test results using a patient portal. ObjectiveAmong a sample of predominantly Black sexual minority men, this study aimed to (1) determine preferences for patient portal use for HIV prevention and (2) test the associations between reported history of discussing HIV results and anticipated willingness to disclose web-based STI/HIV test results with most recent main and nonmain partners using patient portals. MethodsData come from audio-computer self-assisted interview survey data collected during the 3-month visit of a longitudinal cohort study. Univariate analysis assessed patient portal preferences by measuring the valuation rankings of several portal features. Multiple Poisson regression models with robust error variance determined the associations between history of discussing HIV results and willingness to disclose those results using web-based portals by partner type, and to examine criterion validity of the enhancing dyadic communication (EDC) scale to anticipated willingness. ResultsOf the 245 participants, 71% (n=174) were Black and 22% (n=53) were White. Most participants indicated a willingness to share web-based STI/HIV test results with their most recent main partner. Slightly fewer, nonetheless a majority, indicated a willingness to share web-based test results with their most recent nonmain partner. All but 2 patient portal features were valued as high or moderately high priority by >80% of participants. Specifically, tools to help manage HIV (n=183, 75%) and information about pre- and postexposure prophylaxis (both 71%, n=173 and n=175, respectively) were the top-valuated features to include in patient portals for HIV prevention. Discussing HIV test results was significantly associated with increased prevalence of willingness to disclose web-based test results with main (adjusted prevalence ratio [aPR] 1.46, 95% CI 1.21-1.75) and nonmain partners (aPR 1.54, 95% CI 1.23-1.93). ConclusionsOur findings indicate what features Black sexual minority men envision may be included in the patient portal’s design to optimize HIV prevention, further supporting the criterion validity of the EDC scale. Efforts should be made to support Black sexual minority men’s willingness to disclose STI/HIV testing history and status with partners overall as it is associated significantly with a willingness to disclose testing results digitally via patient portals. Future studies should consider discussion behaviors regarding past HIV test results with partners when tailoring interventions that leverage patient portals in disclosure events.
- Published
- 2023
- Full Text
- View/download PDF
5. A Novel Orthotopic Implantation Technique for Osteosarcoma Produces Spontaneous Metastases and Illustrates Dose-Dependent Efficacy of B7-H3-CAR T Cells
- Author
-
Lindsay Jones Talbot, Ashley Chabot, Amy Funk, Phuong Nguyen, Jessica Wagner, Aaron Ross, Heather Tillman, Andrew Davidoff, Stephen Gottschalk, and Christopher DeRenzo
- Subjects
osteosarcoma ,orthotopic ,model ,CAR ,T cell therapy ,B7-H3 ,Immunologic diseases. Allergy ,RC581-607 - Abstract
The outcome for metastatic pediatric osteosarcoma (OS) remains poor. Thus, there is an urgent need to develop novel therapies, and immunotherapy with CAR T cells has the potential to meet this challenge. However, there is a lack of preclinical models that mimic salient features of human disease including reliable development of metastatic disease post orthotopic OS cell injection. To overcome this roadblock, and also enable real-time imaging of metastatic disease, we took advantage of LM7 OS cells expressing firefly luciferase (LM7.ffLuc). LM7.ffLuc were implanted in a collagen mesh into the tibia of mice, and mice reliably developed orthotopic tumors and lung metastases as judged by bioluminescence imaging and histopathological analysis. Intratibial implantation also enabled surgical removal by lower leg amputation and monitoring for metastases development post-surgery. We then used this model to evaluate the antitumor activity of CAR T cells targeting B7-H3, an antigen that is expressed in a broad range of solid tumors including OS. B7-H3-CAR T cells had potent antitumor activity in a dose-dependent manner and inhibited the development of pulmonary metastases resulting in a significant survival advantage. In contrast T cells expressing an inactive B7-H3-CAR had no antitumor activity. Using unmodified LM7 cells also enabled us to demonstrate that B7-H3-CAR T cells traffic to orthotopic tumor sites. Hence, we have developed an orthotopic, spontaneously metastasizing OS model. This model may improve our ability not only to predict the safety and efficacy of current and next generation CAR T cell therapies but also other treatment modalities for metastatic OS.
- Published
- 2021
- Full Text
- View/download PDF
6. Anti-tumor effects of ONC201 in combination with VEGF-inhibitors significantly impacts colorectal cancer growth and survival in vivo through complementary non-overlapping mechanisms
- Author
-
Jessica Wagner, C. Leah Kline, Lanlan Zhou, Vladimir Khazak, and Wafik S. El-Deiry
- Subjects
ONC201 ,Bevacizumab ,Cancer therapy ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Small molecule ONC201 is an investigational anti-tumor agent that upregulates intra-tumoral TRAIL expression and the integrated stress response pathway. A Phase I clinical trial using ONC201 therapy in advanced cancer patients has been completed and the drug has progressed into Phase II trials in several cancer types. Colorectal cancer (CRC) remains one of the leading causes of cancer worldwide and metastatic disease has a poor prognosis. Clinical trials in CRC and other tumor types have demonstrated that therapeutics targeting the vascular endothelial growth factor (VEGF) pathway, such as bevacizumab, are effective in combination with certain chemotherapeutic agents. Methods We investigated the potential combination of VEGF inhibitors such as bevacizumab and its murine-counterpart; along with other anti-angiogenic agents and ONC201 in both CRC xenograft and patient-derived xenograft (PDX) models. We utilized non-invasive imaging and immunohistochemistry to determine potential mechanisms of action. Results Our results demonstrate significant tumor regression or complete tumor ablation in human xenografts with the combination of ONC201 with bevacizumab, and in syngeneic MC38 colorectal cancer xenografts using a murine VEGF-A inhibitor. Imaging demonstrated the impact of this combination on decreasing tumor growth and tumor metastasis. Our results indicate that ONC201 and anti-angiogenic agents act through distinct mechanisms while increasing tumor cell death and inhibiting proliferation. Conclusion With the use of both a murine VEGF inhibitor in syngeneic models, and bevacizumab in human cell line-derived xenografts, we demonstrate that ONC201 in combination with anti-angiogenic therapies such as bevacizumab represents a promising approach for further testing in the clinic for the treatment of CRC.
- Published
- 2018
- Full Text
- View/download PDF
7. Lower serum magnesium is associated with vascular calcification in peritoneal dialysis patients: a cross sectional study
- Author
-
Amber O. Molnar, Mohan Biyani, Ian Hammond, John Paul Harmon, Susan Lavoie, Brendan McCormick, Manish M. Sood, Jessica Wagner, Elena Pena, and Deborah L. Zimmerman
- Subjects
Magnesium ,Peritoneal dialysis ,Vascular calcification ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Abstract Background Coronary artery calcification (CAC) is highly prevalent among dialysis patients and is associated with increased cardiovascular and all cause mortality. Magnesium (Mg) inhibits vascular calcification in animal and in-vitro studies but whether the same effect occurs in humans is uncertain. Methods A single centre cross-sectional study of 80 prevalent peritoneal dialysis (PD) patients; on PD only for a minimum of 3 months. A radiologist blinded to patient status calculated their abdominal aortic calcification (AAC) scores on lateral lumbar spine radiographs, a validated surrogate for CAC. Results Eighty patients provided informed consent and underwent lumbar spine radiography. The mean serum Mg was 0.8 mmol/L (standard deviation 0.2) and mean AAC score 8.9 (minimum 0, maximum 24). A higher serum Mg level was associated with a lower AAC score (R 2 = 0.06, unstandardized coefficient [B] = −7.81, p = 0.03), and remained after adjustment for age, serum phosphate, serum parathyroid hormone, low-density lipoprotein cholesterol, smoking history, and diabetes (model adjusted R 2 = 0.36, serum Mg and AAC score B = −11.44, p = 0.00). This translates to a 0.1 mmol/L increase in serum Mg being independently associated with a 1.1-point decrease in AAC score. Conclusions Our findings suggest that Mg may inhibit vascular calcification. If this association is replicated across larger studies with serial Mg and vascular calcification measurements, interventions that increase serum Mg and their effect on vascular calcification warrant further investigation in the PD population.
- Published
- 2017
- Full Text
- View/download PDF
8. Canadian Rural Women’s Experiences with Rural Primary Health Care Nurse Practitioners
- Author
-
Beverly D Leipert, Jessica Wagner Delaney, Dorothy Forbes, and Cheryl Forchuk
- Subjects
Nursing ,RT1-120 ,Public aspects of medicine ,RA1-1270 - Abstract
Background: In Canada, one in five women lives in a rural area. These rural women often experience different health challenges than urban women, including lower life expectancy, higher rates of disability and cancer, fewer available health care resources and greater distances to access health care services. Nurse practitioners [NPs] provide important primary health care [PHC] services to rural women. Research Objective: The purpose of this research study was to explore rural women’s experiences with primary health care nurse practitioners [PHCNPs]. Method and Sample: In-depth, face-to-face interviews using interpretive description methodology were conducted with nine rural women, aged 18-80, who used NP services in rural southwest Ontario, Canada. Results: The participants in the study particularly appreciated the nursing knowledge of the NP, the time the NPs spent with them, and the thoroughness of the care provided by NPs. These foundational elements of the participants’ experiences with rural NPs created a sense of trust and respect, which lead to a collaborative partnership between the NP and the rural women. Conclusions: Results of this study suggest that these rural women were overwhelmingly satisfied with the care provided by NPs. In particular, they valued the collaborative partnership with the NP. These findings have important implications for rural health care practice, policy, and education.
- Published
- 2011
- Full Text
- View/download PDF
9. Demystifying Digital Archives : Undergraduates, Active Learning, and a Path to Outreach
- Author
-
Webster, Jessica Wagner
- Published
- 2020
10. Umsetzung der DSGVO in der Personalpraxis: Fragen, Antworten, Muster
- Author
-
Clemens Thiele, Jessica Wagner
- Published
- 2019
11. Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease
- Author
-
Jessica Wagner, Karoline Degenhardt, Marleen Veit, Nikolaos Louros, Katerina Konstantoulea, Angelos Skodras, Katleen Wild, Ping Liu, Ulrike Obermüller, Vikas Bansal, Anupriya Dalmia, Lisa M. Häsler, Marius Lambert, Matthias De Vleeschouwer, Hannah A. Davies, Jillian Madine, Deborah Kronenberg-Versteeg, Regina Feederle, Domenico Del Turco, K. Peter R. Nilsson, Tammaryn Lashley, Thomas Deller, Marla Gearing, Lary C. Walker, Peter Heutink, Frederic Rousseau, Joost Schymkowitz, Mathias Jucker, and Jonas J. Neher
- Subjects
PROVIDES ,Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy) ,metabolism [Amyloid beta-Peptides] ,tau Proteins ,Plaque, Amyloid ,Mice, Transgenic ,Mice ,Amyloid beta-Protein Precursor ,MOUSE MODELS ,Alzheimer Disease ,metabolism [Amyloid beta-Protein Precursor] ,ANGIOPATHY ,Humans ,Animals ,Cognitive Dysfunction ,PEPTIDE ,NETWORK ,BRAIN ,DEPOSITION ,Medicinsk bioteknologi (med inriktning mot cellbiologi (inklusive stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci) ,A-BETA ,Serum Amyloid A Protein ,Amyloid beta-Peptides ,Science & Technology ,Multidisciplinary ,Middle Aged ,metabolism [Plaque, Amyloid] ,metabolism [tau Proteins] ,Multidisciplinary Sciences ,PATHOLOGY ,MICE ,Science & Technology - Other Topics ,ddc:500 ,metabolism [Alzheimer Disease] - Abstract
Aggregates of medin amyloid (a fragment of the protein MFG-E8, also known as lactadherin) are found in the vasculature of almost all humans over 50 years of age1,2, making it the most common amyloid currently known. We recently reported that medin also aggregates in blood vessels of ageing wild-type mice, causing cerebrovascular dysfunction3. Here we demonstrate in amyloid-β precursor protein (APP) transgenic mice and in patients with Alzheimer’s disease that medin co-localizes with vascular amyloid-β deposits, and that in mice, medin deficiency reduces vascular amyloid-β deposition by half. Moreover, in both the mouse and human brain, MFG-E8 is highly enriched in the vasculature and both MFG-E8 and medin levels increase with the severity of vascular amyloid-β burden. Additionally, analysing data from 566 individuals in the ROSMAP cohort, we find that patients with Alzheimer’s disease have higher MFGE8 expression levels, which are attributable to vascular cells and are associated with increased measures of cognitive decline, independent of plaque and tau pathology. Mechanistically, we demonstrate that medin interacts directly with amyloid-β to promote its aggregation, as medin forms heterologous fibrils with amyloid-β, affects amyloid-β fibril structure, and cross-seeds amyloid-β aggregation both in vitro and in vivo. Thus, medin could be a therapeutic target for prevention of vascular damage and cognitive decline resulting from amyloid-β deposition in the blood vessels of the brain. Aggregates of medin amyloid (a fragment of the protein MFG-E8, also known as lactadherin) are found in the vasculature of almost all humans over 50 years of age1,2, making it the most common amyloid currently known. We recently reported that medin also aggregates in blood vessels of ageing wild-type mice, causing cerebrovascular dysfunction3. Here we demonstrate in amyloid-β precursor protein (APP) transgenic mice and in patients with Alzheimer’s disease that medin co-localizes with vascular amyloid-β deposits, and that in mice, medin deficiency reduces vascular amyloid-β deposition by half. Moreover, in both the mouse and human brain, MFG-E8 is highly enriched in the vasculature and both MFG-E8 and medin levels increase with the severity of vascular amyloid-β burden. Additionally, analysing data from 566 individuals in the ROSMAP cohort, we find that patients with Alzheimer’s disease have higher MFGE8 expression levels, which are attributable to vascular cells and are associated with increased measures of cognitive decline, independent of plaque and tau pathology. Mechanistically, we demonstrate that medin interacts directly with amyloid-β to promote its aggregation, as medin forms heterologous fibrils with amyloid-β, affects amyloid-β fibril structure, and cross-seeds amyloid-β aggregation both in vitro and in vivo. Thus, medin could be a therapeutic target for prevention of vascular damage and cognitive decline resulting from amyloid-β deposition in the blood vessels of the brain. ispartof: Nature vol:612 issue:7938 pages:123-131 ispartof: location:England status: published
- Published
- 2022
12. Enacted Sexual Minority Stigma, Psychological Distress, and Sexual and Drug Risk Behaviors Among Urban Men Who Have Sex with Men (MSM)
- Author
-
Francesca Silvestri, Carla Tilchin, Jessica Wagner, Matthew M. Hamill, Anne Rompalo, Khalil G. Ghanem, Christina Schumacher, Sebastian Ruhs, Adena Greenbaum, Carl Latkin, and Jacky M. Jennings
- Subjects
Infectious Diseases ,Social Psychology ,Public Health, Environmental and Occupational Health - Abstract
Urban Black men who have sex with men (MSM) bear a disproportionate burden of HIV and syphilis in the U.S. Experiences of enacted sexual minority stigma and psychological distress among these men may be associated with HIV/STI sexual and drug risk behaviors. The objective was to determine the associations between enacted sexual minority stigma, psychological distress, and sexual and drug risk behaviors. In an urban prospective cohort study, survey measures assessed past 3-month exposure to enacted sexual minority stigma, psychological distress, and sexual and drug risk behaviors. Multivariable logistic regression models were utilized for hypothesis testing. The Black MSM (N = 140) reported the following: 22.1% experiences of enacted sexual minority stigma, 39% high levels of psychological distress, 48.6% 1 sex partner, 8.6% transactional sex, and 6% injection drug use (IDU). In models adjusted for age and education, enacted sexual minority stigma significantly increased the odds of reporting 1 sex partner, transactional sex, and IDU. Adjusting additionally for homelessness, the association between enacted sexual minority stigma and transactional sex remained significant. Adding psychological distress to this model showed a significant association between psychological distress and transactional sex, while the association was no longer significant for transactional sex. These findings highlight some of the complex psycho-social relationships that may be associated with sexual and drug risk behaviors among Black MSM placing them at increased risk for HIV and syphilis.Hombres urbanos de raza Negra que tienen sexo con hombres (HSH) sobrellevan una carga desproporcionada de VIH y sífilis en los EE.UU. Experiencias de estigma efectivo de minoría sexual y angustia psicológica entre estos hombres pudiese ser asociado con conductas sexuales de riesgo VIH/ITS y drogas. El objetivo era determinar las asociaciones entre un estigma efectivo de minoría sexual, angustia psicológica, y comportamientos sexuales y de riesgo de drogas. En un estudio de cohortes prospectivo urbano, las medidas de la encuesta evaluada en los últimos tres meses de exposición al estigma efectivo, angustia psicológica, y sus conductas sexuales y comportamientos riesgoso de drogas. Modelos de regresión logística multivariante se utilizaron para la prueba de hipótesis. Los HSH de raza negra (N = 140) reportaron lo siguiente: 22.1% experiencias de estigma efectivo, 39% niveles altos de angustia psicológica, 48.6% y 1 pareja sexual, 8.6% sexo transaccional, y 6% uso de drogas inyectables (UDI). En modelos ajustados a edad y educación, un estigma efectivo de minoría sexual aumentó de manera significante las probabilidades de reportar y 1 pareja sexual, sexo transaccional, y UDI. Ajustando adicionalmente para personas sin vivienda, la asociación entre estigma efectivo de minoría sexual y sexo transaccional permaneció significante. La adición de angustia psicológica al modelo mostró una asociación significativa entre angustia psicológica y sexo transaccional, mientras que la asociación ya no era significativa para el sexo transaccional. Estos resultados destacan algunas de las complejas relaciones psicosociales que pudiesen estar asociadas con conductas sexuales y de riesgo de drogas entre HSH de raza negra, poniéndolos a mayor riesgo de contraer VIH y sífilis.
- Published
- 2022
13. "Filling the Gaps": Oral Histories and Underdocumented Populations in "The American Archivist", 1938–2011
- Author
-
Webster, Jessica Wagner
- Published
- 2016
14. Supplementary Figures 11-18 from Antitumor Effects of CAR T Cells Redirected to the EDB Splice Variant of Fibronectin
- Author
-
Stephen Gottschalk, Giedre Krenciute, Heather Tillman, Shondra M. Pruett-Miller, Shaina N. Porter, Jinghui Zhang, Deanna Langfitt, Alejandro Allo Anido, Timothy I. Shaw, Elizabeth Wickman, and Jessica Wagner
- Abstract
Supplementary Figures 11-18
- Published
- 2023
15. Data from Antitumor Effects of CAR T Cells Redirected to the EDB Splice Variant of Fibronectin
- Author
-
Stephen Gottschalk, Giedre Krenciute, Heather Tillman, Shondra M. Pruett-Miller, Shaina N. Porter, Jinghui Zhang, Deanna Langfitt, Alejandro Allo Anido, Timothy I. Shaw, Elizabeth Wickman, and Jessica Wagner
- Abstract
Chimeric antigen receptor (CAR) T-cell therapy has had limited success in early-phase clinical studies for solid tumors. Lack of efficacy is most likely multifactorial, including a limited array of targetable antigens. We reasoned that targeting the cancer-specific extra domain B (EDB) splice variant of fibronectin might overcome this limitation because it is abundantly secreted by cancer cells and adheres to their cell surface. In vitro, EDB-CAR T cells recognized and killed EDB-positive tumor cells. In vivo, 1 × 106 EDB-CAR T cells had potent antitumor activity in both subcutaneous and systemic tumor xenograft models, resulting in a significant survival advantage in comparison with control mice. EDB-CAR T cells also targeted the tumor vasculature, as judged by IHC and imaging, and their antivascular activity was dependent on the secretion of EDB by tumor cells. Thus, targeting tumor-specific splice variants such as EDB with CAR T cells is feasible and has the potential to improve the efficacy of CAR T-cell therapy.
- Published
- 2023
16. Supplemental Table 2 from Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression
- Author
-
Edna Cukierman, Igor Astsaturov, Kerry S. Campbell, Suraj Peri, Matthew G. Vander Heiden, Wafik S. El-Deiry, Huamin Wang, Andres J. Klein-Szanto, Siddharth Balachandran, Karthik Devarajan, Warren D. Kruger, Yinfei Tan, Harvey H. Hensley, Kathy Q. Cai, Yan Zhou, Diana Restifo, Roshan J. Thapa, Ruchi Malik, Dustin Rollins, Tiffany Luong, Sapna Gupta, Tatiana Pazina, Linara Gabitova, Allison N. Lau, Alexander Muir, Jessica Wagner, Janusz Franco-Barraza, Débora Barbosa Vendramini-Costa, and Ralph Francescone
- Abstract
TMA Clinical Data
- Published
- 2023
17. Supplemental Table 4 from Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression
- Author
-
Edna Cukierman, Igor Astsaturov, Kerry S. Campbell, Suraj Peri, Matthew G. Vander Heiden, Wafik S. El-Deiry, Huamin Wang, Andres J. Klein-Szanto, Siddharth Balachandran, Karthik Devarajan, Warren D. Kruger, Yinfei Tan, Harvey H. Hensley, Kathy Q. Cai, Yan Zhou, Diana Restifo, Roshan J. Thapa, Ruchi Malik, Dustin Rollins, Tiffany Luong, Sapna Gupta, Tatiana Pazina, Linara Gabitova, Allison N. Lau, Alexander Muir, Jessica Wagner, Janusz Franco-Barraza, Débora Barbosa Vendramini-Costa, and Ralph Francescone
- Abstract
RNAseq
- Published
- 2023
18. Data from Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression
- Author
-
Edna Cukierman, Igor Astsaturov, Kerry S. Campbell, Suraj Peri, Matthew G. Vander Heiden, Wafik S. El-Deiry, Huamin Wang, Andres J. Klein-Szanto, Siddharth Balachandran, Karthik Devarajan, Warren D. Kruger, Yinfei Tan, Harvey H. Hensley, Kathy Q. Cai, Yan Zhou, Diana Restifo, Roshan J. Thapa, Ruchi Malik, Dustin Rollins, Tiffany Luong, Sapna Gupta, Tatiana Pazina, Linara Gabitova, Allison N. Lau, Alexander Muir, Jessica Wagner, Janusz Franco-Barraza, Débora Barbosa Vendramini-Costa, and Ralph Francescone
- Abstract
Pancreatic ductal adenocarcinoma (PDAC) has a poor 5-year survival rate and lacks effective therapeutics. Therefore, it is of paramount importance to identify new targets. Using multiplex data from patient tissue, three-dimensional coculturing in vitro assays, and orthotopic murine models, we identified Netrin G1 (NetG1) as a promoter of PDAC tumorigenesis. We found that NetG1+ cancer-associated fibroblasts (CAF) support PDAC survival, through a NetG1-mediated effect on glutamate/glutamine metabolism. Also, NetG1+ CAFs are intrinsically immunosuppressive and inhibit natural killer cell–mediated killing of tumor cells. These protumor functions are controlled by a signaling circuit downstream of NetG1, which is comprised of AKT/4E-BP1, p38/FRA1, vesicular glutamate transporter 1, and glutamine synthetase. Finally, blocking NetG1 with a neutralizing antibody stunts in vivo tumorigenesis, suggesting NetG1 as potential target in PDAC.Significance:This study demonstrates the feasibility of targeting a fibroblastic protein, NetG1, which can limit PDAC tumorigenesis in vivo by reverting the protumorigenic properties of CAFs. Moreover, inhibition of metabolic proteins in CAFs altered their immunosuppressive capacity, linking metabolism with immunomodulatory function.See related commentary by Sherman, p. 230.This article is highlighted in the In This Issue feature, p. 211
- Published
- 2023
19. Supplemental Table 1 from Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression
- Author
-
Edna Cukierman, Igor Astsaturov, Kerry S. Campbell, Suraj Peri, Matthew G. Vander Heiden, Wafik S. El-Deiry, Huamin Wang, Andres J. Klein-Szanto, Siddharth Balachandran, Karthik Devarajan, Warren D. Kruger, Yinfei Tan, Harvey H. Hensley, Kathy Q. Cai, Yan Zhou, Diana Restifo, Roshan J. Thapa, Ruchi Malik, Dustin Rollins, Tiffany Luong, Sapna Gupta, Tatiana Pazina, Linara Gabitova, Allison N. Lau, Alexander Muir, Jessica Wagner, Janusz Franco-Barraza, Débora Barbosa Vendramini-Costa, and Ralph Francescone
- Abstract
Microarray
- Published
- 2023
20. Supplemental Table 8 from Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression
- Author
-
Edna Cukierman, Igor Astsaturov, Kerry S. Campbell, Suraj Peri, Matthew G. Vander Heiden, Wafik S. El-Deiry, Huamin Wang, Andres J. Klein-Szanto, Siddharth Balachandran, Karthik Devarajan, Warren D. Kruger, Yinfei Tan, Harvey H. Hensley, Kathy Q. Cai, Yan Zhou, Diana Restifo, Roshan J. Thapa, Ruchi Malik, Dustin Rollins, Tiffany Luong, Sapna Gupta, Tatiana Pazina, Linara Gabitova, Allison N. Lau, Alexander Muir, Jessica Wagner, Janusz Franco-Barraza, Débora Barbosa Vendramini-Costa, and Ralph Francescone
- Abstract
Amino Acid- Mass Spec
- Published
- 2023
21. Supplemental Table 3 from Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression
- Author
-
Edna Cukierman, Igor Astsaturov, Kerry S. Campbell, Suraj Peri, Matthew G. Vander Heiden, Wafik S. El-Deiry, Huamin Wang, Andres J. Klein-Szanto, Siddharth Balachandran, Karthik Devarajan, Warren D. Kruger, Yinfei Tan, Harvey H. Hensley, Kathy Q. Cai, Yan Zhou, Diana Restifo, Roshan J. Thapa, Ruchi Malik, Dustin Rollins, Tiffany Luong, Sapna Gupta, Tatiana Pazina, Linara Gabitova, Allison N. Lau, Alexander Muir, Jessica Wagner, Janusz Franco-Barraza, Débora Barbosa Vendramini-Costa, and Ralph Francescone
- Abstract
TMA IHC Scores
- Published
- 2023
22. Supplementary Figures from Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression
- Author
-
Edna Cukierman, Igor Astsaturov, Kerry S. Campbell, Suraj Peri, Matthew G. Vander Heiden, Wafik S. El-Deiry, Huamin Wang, Andres J. Klein-Szanto, Siddharth Balachandran, Karthik Devarajan, Warren D. Kruger, Yinfei Tan, Harvey H. Hensley, Kathy Q. Cai, Yan Zhou, Diana Restifo, Roshan J. Thapa, Ruchi Malik, Dustin Rollins, Tiffany Luong, Sapna Gupta, Tatiana Pazina, Linara Gabitova, Allison N. Lau, Alexander Muir, Jessica Wagner, Janusz Franco-Barraza, Débora Barbosa Vendramini-Costa, and Ralph Francescone
- Abstract
18 supplementary figures and corresponding legends
- Published
- 2023
23. Key Resources Table from Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression
- Author
-
Edna Cukierman, Igor Astsaturov, Kerry S. Campbell, Suraj Peri, Matthew G. Vander Heiden, Wafik S. El-Deiry, Huamin Wang, Andres J. Klein-Szanto, Siddharth Balachandran, Karthik Devarajan, Warren D. Kruger, Yinfei Tan, Harvey H. Hensley, Kathy Q. Cai, Yan Zhou, Diana Restifo, Roshan J. Thapa, Ruchi Malik, Dustin Rollins, Tiffany Luong, Sapna Gupta, Tatiana Pazina, Linara Gabitova, Allison N. Lau, Alexander Muir, Jessica Wagner, Janusz Franco-Barraza, Débora Barbosa Vendramini-Costa, and Ralph Francescone
- Abstract
Lists all key resources and reagents
- Published
- 2023
24. Supplemental Tables 5-7 from Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression
- Author
-
Edna Cukierman, Igor Astsaturov, Kerry S. Campbell, Suraj Peri, Matthew G. Vander Heiden, Wafik S. El-Deiry, Huamin Wang, Andres J. Klein-Szanto, Siddharth Balachandran, Karthik Devarajan, Warren D. Kruger, Yinfei Tan, Harvey H. Hensley, Kathy Q. Cai, Yan Zhou, Diana Restifo, Roshan J. Thapa, Ruchi Malik, Dustin Rollins, Tiffany Luong, Sapna Gupta, Tatiana Pazina, Linara Gabitova, Allison N. Lau, Alexander Muir, Jessica Wagner, Janusz Franco-Barraza, Débora Barbosa Vendramini-Costa, and Ralph Francescone
- Abstract
Sup Tables 5-7- Amino Acid Biochrom
- Published
- 2023
25. Supplementary Figure Legends from ONC201 Demonstrates Antitumor Effects in Both Triple-Negative and Non–Triple-Negative Breast Cancers through TRAIL-Dependent and TRAIL-Independent Mechanisms
- Author
-
Wafik S. El-Deiry, Wolfgang Oster, Varun V. Prabhu, David T. Dicker, Bora Lim, Jessica Wagner, Ozan C. Küçükkase, Christina L.B. Kline, and Marie D. Ralff
- Abstract
Supplementary Figure Legends
- Published
- 2023
26. Fetale Alkoholspektrum-Störungen im Erwachsenenalter – Ergebnisse aus einer diagnostischen Sprechstunde
- Author
-
Tanja Sappok, Marlene Tergeist, Björn Kruse, and Jessica Wagner
- Subjects
Psychiatry and Mental health ,Neurology ,Neurology (clinical) - Abstract
Zusammenfassung Ziel der Studie Fetale Alkoholspektrum-Störungen sind nicht nur häufig, sie sind aufgrund des hohen Risikos für psychiatrische Komorbiditäten auch im Erwachsenenalter klinisch relevant. Die diagnostische Abklärung im Erwachsenenalter ist die Voraussetzung für eine zielgerichtete Behandlung und bedarfsgerechte Unterstützung. Methodik In einer Metropolenregion wurde zwischen Mai 2015 und Juli 2020 bei 80 Personen der Verdacht auf eine FASD diagnostisch abgeklärt. Die Ergebnisse dieser interdisziplinären Diagnostik wurden systematisch ausgewertet und die klinischen Charakteristika der Personen mit bzw. ohne FASD analysiert. Ergebnisse Bei ca. 70% der Inanspruchnahmepopulation wurde eine Diagnose aus dem FAS-Spektrum gestellt. Personen mit FASD zeigten häufiger eine Lernbehinderung (50 vs. 33%) oder Intelligenzminderung (40 vs. 10%), während keine Gruppenunterschiede für Alter und Geschlecht bestanden. Psychiatrische Komorbiditäten, insbesondere Depressionen (39%) und Abhängigkeitserkrankungen (31%), waren in beiden Gruppen häufig. Schlussfolgerung Im Rahmen einer multiprofessionellen standardisierten Diagnostik ist die FASD Abklärung auch im Erwachsenenalter möglich und nötig. Die Entwicklung standardisierter und spezifischer Diagnosekriterien für Erwachsene ist sinnvoll.
- Published
- 2022
27. Correction: Desires for Individual- and Interpersonal-Level Patient Portal Use for HIV Prevention Among Urban Sexual Minority Men: Cross-sectional Study (Preprint)
- Author
-
Kevon-Mark P Jackman, Carla Tilchin, Jessica Wagner, Ryan E Flinn, Maria Trent, Carl Latkin, Sebastian Ruhs, Errol L Fields, Matthew M Hamill, Carlos Mahaffey, Adena Greenbaum, and Jacky M Jennings
- Abstract
UNSTRUCTURED
- Published
- 2023
28. Psychotherapie bei Störungen der Intelligenzentwicklung – aktuelle Evidenz und praktische Umsetzung
- Author
-
Tanja Sappok, Mareike Bayer, Almut Helmes, Anika Gabriel, Jessica Wagner, Anne Styp von Rekowski, and Marlene Tergeist
- Subjects
Psychiatry and Mental health ,Neurology ,Neurology (clinical) ,General Medicine - Abstract
People with adisorder of intellectual development (German draft of the ICD-11, which came into force on 1January 2022) suffer more frequently from mental illnesses. According to the international treatment guidelines multimodal approaches should include not only psychopharmacological treatment, but also disorder-specific psychotherapeutic methods. These psychotherapeutic interventions have to be adapted to the communicative and cognitive abilities (performance diagnostics with IQ tests) as well as the emotional developmental stage (developmental diagnostics, e.g., with the scale of emotional development, short version, SED-S2; [1]). To ensure this, the rules of simple language should be observed and when appropriate relatives or caregivers should be involved in the therapeutic process. The effectiveness of cognitive behavioral therapy has received most scientific attention, especially for affective disorders. Posttraumatic stress disorders can be validly treated with eye movement desensitization and reprocessing (EMDR). There is also good evidence for exposure therapy with reinforcement in the treatment of anxiety disorders. © 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature., Menschen mit einer Störung der Intelligenzentwicklung (deutsche Entwurfsfassung der ICD-11, in Kraft getreten am 01.01.2022) leiden überdurchschnittlich häufig an psychischen Erkrankungen. Die leitliniengerechte, multimodale Behandlung beinhaltet neben psychopharmakologischen auch störungsspezifische psychotherapeutische Methoden, die auf die kommunikativen und kognitiven Fähigkeiten (Leistungsdiagnostik mit IQ-Tests) sowie den emotionalen Entwicklungsstand (Entwicklungsdiagnostik z. B. mit der Skala der emotionalen Entwicklung SEED-2) der Person angepasst werden sollten [1]. Dabei sind die Regeln der leichten Sprache zu beachten und ggf. Angehörige bzw. Bezugspersonen in die Therapieumsetzung einzubeziehen. Am besten untersucht ist die Wirksamkeit der kognitiven Verhaltenstherapie, insbesondere für affektive Störungen. Posttraumatische Belastungsstörungen sind valide mit EMDR („eye movement desensitization and reprocessing“) behandelbar. Eine gute Evidenz gibt es für die Expositionstherapie mit Verstärkung in der Behandlung von Angsterkrankungen.
- Published
- 2023
29. 50 Years Ago in TheJournalofPediatrics: Pediatric Nurse Practitioners: 50 Years of Partnering for Children's Health
- Author
-
Jessica, Wagner and Terrill, Bravender
- Published
- 2022
30. Acceptability and Feasibility of Geographically Explicit Ecological Momentary Assessment Among Men Who Have Sex with Men
- Author
-
Carla Tilchin, Jacky M. Jennings, Jessica Wagner, David H. Epstein, Isabelle Sheck, and Albert J. Burgess-Hull
- Subjects
Male ,medicine.medical_specialty ,Data collection ,Ecology ,Ecological Momentary Assessment ,Public health ,Human immunodeficiency virus (HIV) ,Risk behavior ,HIV Infections ,medicine.disease ,medicine.disease_cause ,Men who have sex with men ,Sexual and Gender Minorities ,Arts and Humanities (miscellaneous) ,medicine ,Feasibility Studies ,Humans ,Population study ,Syphilis ,Homosexuality, Male ,Psychology ,mHealth ,General Psychology - Abstract
Syphilis among men who have sex with men (MSM) has increased greatly in the past twenty years in the U.S. Geographically explicit ecological momentary assessment (GEMA), in which behaviors are geotagged and contextualized in time and space, may contribute to a greater understanding of transmission risk. The objective was to determine the acceptability and feasibility of GEMA for assessing HIV and syphilis transmission risk behaviors among a sample of MSM. Participants responded to a brief survey five times a day for two weeks. Feasibility was measured by participant recruitment, enrollment, prompts received and answered, geotagged prompts, and technical interference with data collection. Acceptability was measured by ratings of enjoyment and willingness for future participation. Summaries of five behavioral measures from the brief survey were calculated. Among the 83 participants contacted, 67.5% (56) expressed interest, 98% (55) were scheduled, and 81.8% (45) were enrolled. Participants answered 78.3% (2,277) of prompts received and 87.7% (1,998) of answered prompts were geotagged. Overall, 70.5% (31) enjoyed participating and 91.1% (41) were willing to participate in the future. Among prompts answered, missingness was low for five behavioral measures (range 0.2% (4) to 0.7% (16)). Feasibility and acceptability were high and missingness was low on behavioral measures in this MSM study population. Most participants reported that they would participate again. Future work should focus on whether GEMA improves our understanding of syphilis and HIV transmission risk.
- Published
- 2021
31. Sexual Violence in Sport: Expanding Awareness and Knowledge for Sports Medicine Providers
- Author
-
Lee Goldfarb, Jennifer Scott Koontz, Jessica Wagner, Kathryn H. Schmitz, Elizabeth Joy, Rachael E. Flatt, Judith A. Cohen, Colin Nelson, Sheila A. Dugan, Susan Greinig, and Stanley A. Herring
- Subjects
medicine.medical_specialty ,Sports medicine ,Best practice ,education ,Specific knowledge ,Sports Medicine ,Multidisciplinary approach ,Health care ,medicine ,Humans ,Orthopedics and Sports Medicine ,Students ,Sexual violence ,biology ,business.industry ,Athletes ,Sex Offenses ,Public Health, Environmental and Occupational Health ,General Medicine ,biology.organism_classification ,Mental health ,United States ,Family medicine ,business ,human activities ,Sports - Abstract
Athletes are vulnerable to sexual violence. Perpetrators of sexual violence may be a trusted coach, a member of the health care team, or a peer. The consequences of sexual violence are wide ranging, resulting in immediate and long-term physical and mental health outcomes that require recognition and comprehensive, multidisciplinary care. Sports medicine providers need to have specific knowledge and skill to care for athletes who experience sexual violence. Several sports organizations (e.g., International Olympic Committee, United States Olympic and Paralympic Committee, the National Collegiate Athletic Association, and the National Athletic Trainers' Association) have developed policies and procedures to prevent sexual violence and help sports medicine specialists provide care and services for athletes affected by sexual violence. Nevertheless, there remains a need for clinical guidelines, screening tools, and education, as well as clinical best practices to address sexual violence in sports medicine.
- Published
- 2021
32. Desires for Individual- and Interpersonal-Level Patient Portal Use for HIV Prevention Among Urban Sexual Minority Men: Cross-sectional Study (Preprint)
- Author
-
Kevon-Mark P Jackman, Carla Tilchin, Jessica Wagner, Ryan E Flinn, Maria Trent, Carl Latkin, Sebastian Ruhs, Errol L Fields, Matthew M Hamill, Carlos Mahaffey, Adena Greenbaum, and Jacky M Jennings
- Abstract
BACKGROUND Gay, bisexual, and other sexual minority men have expressed the acceptability of patient portals as tools for supporting HIV prevention behaviors, including facilitating disclosure of HIV and other sexually transmitted infection (STI/HIV) laboratory test results to sex partners. However, these studies, in which Black or African American sexual minority men were undersampled, failed to determine the relationship of reported history of discussing HIV results with sex partners and anticipated willingness to disclose web-based STI/HIV test results using a patient portal. OBJECTIVE Among a sample of predominantly Black sexual minority men, this study aimed to (1) determine preferences for patient portal use for HIV prevention and (2) test the associations between reported history of discussing HIV results and anticipated willingness to disclose web-based STI/HIV test results with most recent main and nonmain partners using patient portals. METHODS Data come from audio-computer self-assisted interview survey data collected during the 3-month visit of a longitudinal cohort study. Univariate analysis assessed patient portal preferences by measuring the valuation rankings of several portal features. Multiple Poisson regression models with robust error variance determined the associations between history of discussing HIV results and willingness to disclose those results using web-based portals by partner type, and to examine criterion validity of the enhancing dyadic communication (EDC) scale to anticipated willingness. RESULTS Of the 245 participants, 71% (n=174) were Black and 22% (n=53) were White. Most participants indicated a willingness to share web-based STI/HIV test results with their most recent main partner. Slightly fewer, nonetheless a majority, indicated a willingness to share web-based test results with their most recent nonmain partner. All but 2 patient portal features were valued as high or moderately high priority by >80% of participants. Specifically, tools to help manage HIV (n=183, 75%) and information about pre- and postexposure prophylaxis (both 71%, n=173 and n=175, respectively) were the top-valuated features to include in patient portals for HIV prevention. Discussing HIV test results was significantly associated with increased prevalence of willingness to disclose web-based test results with main (adjusted prevalence ratio [aPR] 1.46, 95% CI 1.21-1.75) and nonmain partners (aPR 1.54, 95% CI 1.23-1.93). CONCLUSIONS Our findings indicate what features Black sexual minority men envision may be included in the patient portal’s design to optimize HIV prevention, further supporting the criterion validity of the EDC scale. Efforts should be made to support Black sexual minority men’s willingness to disclose STI/HIV testing history and status with partners overall as it is associated significantly with a willingness to disclose testing results digitally via patient portals. Future studies should consider discussion behaviors regarding past HIV test results with partners when tailoring interventions that leverage patient portals in disclosure events. CLINICALTRIAL
- Published
- 2022
33. Demenztest für Menschen mit Intelligenzminderung
- Author
-
Jessica Wagner and Christoph Weber
- Subjects
Psychiatry and Mental health ,Neuropsychology and Physiological Psychology ,business.industry ,Cognitive Neuroscience ,Medicine ,business - Published
- 2021
34. Antitumor Effects of CAR T Cells Redirected to the EDB Splice Variant of Fibronectin
- Author
-
Elizabeth Wickman, Alejandro Allo Anido, Giedre Krenciute, Timothy I. Shaw, Shaina N. Porter, Shondra M. Pruett-Miller, Stephen Gottschalk, Heather Tillman, Deanna Langfitt, Jessica Wagner, and Jinghui Zhang
- Subjects
0301 basic medicine ,Cancer Research ,RNA Splicing ,T-Lymphocytes ,medicine.medical_treatment ,Primary Cell Culture ,Immunology ,Cell ,Biology ,Immunotherapy, Adoptive ,Article ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Antigen ,Antigens, Neoplasm ,In vivo ,Cell Line, Tumor ,Neoplasms ,Human Umbilical Vein Endothelial Cells ,medicine ,Animals ,Humans ,Protein Isoforms ,Receptors, Chimeric Antigen ,Immunotherapy ,Xenograft Model Antitumor Assays ,Coculture Techniques ,Healthy Volunteers ,In vitro ,Chimeric antigen receptor ,Fibronectins ,Neoplasm Proteins ,030104 developmental biology ,medicine.anatomical_structure ,Cell culture ,030220 oncology & carcinogenesis ,Cancer cell ,Cancer research ,Feasibility Studies - Abstract
Chimeric antigen receptor (CAR) T-cell therapy has had limited success in early-phase clinical studies for solid tumors. Lack of efficacy is most likely multifactorial, including a limited array of targetable antigens. We reasoned that targeting the cancer-specific extra domain B (EDB) splice variant of fibronectin might overcome this limitation because it is abundantly secreted by cancer cells and adheres to their cell surface. In vitro, EDB-CAR T cells recognized and killed EDB-positive tumor cells. In vivo, 1 × 106 EDB-CAR T cells had potent antitumor activity in both subcutaneous and systemic tumor xenograft models, resulting in a significant survival advantage in comparison with control mice. EDB-CAR T cells also targeted the tumor vasculature, as judged by IHC and imaging, and their antivascular activity was dependent on the secretion of EDB by tumor cells. Thus, targeting tumor-specific splice variants such as EDB with CAR T cells is feasible and has the potential to improve the efficacy of CAR T-cell therapy.
- Published
- 2021
35. Abstract 1778: B7-H3-CAR T-cell therapy in immune-competent osteosarcoma models: Regnase-1 KO overcomes limited CAR T-cell expansion
- Author
-
Adeleye O. Adeshakin, Peipei Zhou, Jean-Yves Métais, Phuong Nguyen, Scott Perry, Heather Sheppard, Xiang Sun, Trevor Cunningham, Hao Shi, Jessica Wagner, Jason T. Yustein, Christopher DeRenzo, Giedre Krenciute, Hongbo Chi, and Stephen Gottschalk
- Subjects
Cancer Research ,Oncology - Abstract
Chimeric antigen receptor (CAR) T-cell therapy offers promise to improve outcomes for pediatric patients with recurrent/refractory osteosarcoma (OS), a ‘poor-prognosis’ cancer. However, early-phase clinical studies have shown limited activity despite potent antitumor activity in preclinical xenograft models, highlighting the need to develop better preclinical models. B7-H3 has emerged as a promising immunotherapeutic target for pediatric solid tumors including OS, and we and other investigators are actively exploring B7-H3-CAR T cell therapies in early-phase clinical studies. Our goal was to develop a murine immunocompetent OS model (F331) for the realistic pre-clinical evaluation of B7-H3-CAR T cells and to explore additional genetic modifications to improve their effector function. We generated murine B7-H3-CAR T cells expressing a 2nd generation B7-H3-CD28.ζ CAR by retroviral transduction. In vitro, B7-H3-CAR T cells recognized B7-H3-positive F331 cells as judged by IFNγ production and cytolytic activity in contrast to B7-H3-negative tumor cells; Control (ctrl) CAR T-cells recognizing an irrelevant antigen (SP6) did not recognize or kill B7-H3-positive tumor cells confirming specificity. Since lung is the primary OS metastasis site, we focused on the intravenous (i.v.) disseminated lung F331 OS metastasis model. In this model, a single i.v. infusion of 5x106 CD8+ B7-H3-CAR T cells demonstrated significant antitumor activity compared to CD8+ ctrl CAR T cells, resulting in a significant survival advantage (median: 70 vs 38 days respectively). Unfortunately, tumors invariably recurred. We found limited B7-H3-CAR T cell expansion and persistence, even though recurring tumors still expressed B7-H3, excluding tumor antigen escape mechanism. We therefore embarked on a comprehensive screen to knock out (KO) known negative regulators of T-cell function, starting with Regnase-1 (Reg-1). Reg-1 is known to have RNase activity and to regulate activation of immune cells. KO of Reg-1 in CD8+ B7-H3-CAR T cells improved their expansion post-infusion in spleen and lungs as judged by flow cytometric analysis without systemic toxicities based on mice body weight assessment. This resulted in a significant improvement in overall survival in comparison to control KO B7-H3-CAR T cells at a cell dose (1x106) at which ctrl-KO CD8+ B7-H3-CAR T cells were ineffective. Reg1-KO ctrl CAR T cells had no therapeutic benefit, excluding nonspecific effects. In summary, we have established an immune-competent OS model to evaluate the effector function of B7-H3-CAR T cells and have demonstrated the advantage given by 2nd genetic modifications to enhance their antitumor activity. We are currently using this model to define mechanisms of immune resistance with the goal of further enhancing OS-redirected CAR T-cell therapy. Citation Format: Adeleye O. Adeshakin, Peipei Zhou, Jean-Yves Métais, Phuong Nguyen, Scott Perry, Heather Sheppard, Xiang Sun, Trevor Cunningham, Hao Shi, Jessica Wagner, Jason T. Yustein, Christopher DeRenzo, Giedre Krenciute, Hongbo Chi, Stephen Gottschalk. B7-H3-CAR T-cell therapy in immune-competent osteosarcoma models: Regnase-1 KO overcomes limited CAR T-cell expansion [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 1778.
- Published
- 2023
36. Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression
- Author
-
Kathy Q. Cai, Kerry S. Campbell, Tiffany Luong, Tatiana Pazina, Wafik S. El-Deiry, Allison N. Lau, Ruchi Malik, Débora Barbosa Vendramini-Costa, Harvey Hensley, Alexander Muir, Dustin Rollins, Ralph Francescone, Yan Zhou, Siddharth Balachandran, Edna Cukierman, Sapna Gupta, Karthik Devarajan, Warren D. Kruger, Huamin Wang, Roshan J. Thapa, Matthew G. Vander Heiden, Jessica Wagner, Yinfei Tan, Diana Restifo, Andres J. Klein-Szanto, Suraj Peri, Igor Astsaturov, Linara Gabitova, and Janusz Franco-Barraza
- Subjects
0301 basic medicine ,p38 mitogen-activated protein kinases ,Vesicular glutamate transporter 1 ,Adenocarcinoma ,Biology ,medicine.disease_cause ,03 medical and health sciences ,0302 clinical medicine ,In vivo ,Glutamine synthetase ,Netrin ,Tumor Microenvironment ,medicine ,Humans ,Neutralizing antibody ,Protein kinase B ,Immunosuppression Therapy ,Nutritional Support ,Gene Expression Regulation, Neoplastic ,Pancreatic Neoplasms ,030104 developmental biology ,Oncology ,030220 oncology & carcinogenesis ,biology.protein ,Cancer research ,Netrins ,Carcinogenesis ,Carcinoma, Pancreatic Ductal - Abstract
Pancreatic ductal adenocarcinoma (PDAC) has a poor 5-year survival rate and lacks effective therapeutics. Therefore, it is of paramount importance to identify new targets. Using multiplex data from patient tissue, three-dimensional coculturing in vitro assays, and orthotopic murine models, we identified Netrin G1 (NetG1) as a promoter of PDAC tumorigenesis. We found that NetG1+ cancer-associated fibroblasts (CAF) support PDAC survival, through a NetG1-mediated effect on glutamate/glutamine metabolism. Also, NetG1+ CAFs are intrinsically immunosuppressive and inhibit natural killer cell–mediated killing of tumor cells. These protumor functions are controlled by a signaling circuit downstream of NetG1, which is comprised of AKT/4E-BP1, p38/FRA1, vesicular glutamate transporter 1, and glutamine synthetase. Finally, blocking NetG1 with a neutralizing antibody stunts in vivo tumorigenesis, suggesting NetG1 as potential target in PDAC. Significance: This study demonstrates the feasibility of targeting a fibroblastic protein, NetG1, which can limit PDAC tumorigenesis in vivo by reverting the protumorigenic properties of CAFs. Moreover, inhibition of metabolic proteins in CAFs altered their immunosuppressive capacity, linking metabolism with immunomodulatory function. See related commentary by Sherman, p. 230. This article is highlighted in the In This Issue feature, p. 211
- Published
- 2021
37. Demystifying Digital Archives: Undergraduates, Active Learning, and a Path to Outreach
- Author
-
Jessica Wagner Webster
- Subjects
Library and Information Sciences ,Education - Abstract
This article outlines the development of a three-credit digital archives course designed for undergraduates. In it, students study basic archival and digital archives terminology and learn about how these concepts can help them understand current events. This course strives not only to help students develop critical thinking skills by engaging with primary source content; it also helps familiarize students with archives, archivists, and the importance of archival work. In addition, the course relies heavily on active learning techniques, which allow students to participate in decision-making activities in archival work, giving them an appreciation for the labor involved. The course therefore fulfills an outreach function: It shows students why archives are relevant to their lives and to the world around them. The article places this course in the context of archival education for undergraduates and non-professionals, highlighting the benefits this approach offers for students and for the professional archival field.
- Published
- 2020
38. Amphiphilic Polyphenylene Dendron Conjugates for Surface Remodeling of Adenovirus 5
- Author
-
Volker Mailänder, Jessica Wagner, Yuzhou Wu, Longjie Li, Katharina Landfester, Klaus Müllen, David Y. W. Ng, Tanja Weil, Johanna Simon, and Lea Krutzke
- Subjects
Surface (mathematics) ,Dendrimers ,Cell Survival ,Polymers ,Surface Properties ,viruses ,Protein Corona ,CHO Cells ,Gene delivery ,010402 general chemistry ,01 natural sciences ,Catalysis ,Adenoviridae ,Transduction (genetics) ,Cricetulus ,Cricetinae ,Dendrimer ,Amphiphile ,gene technology ,Animals ,Research Articles ,amphiphiles ,Cycloaddition Reaction ,010405 organic chemistry ,Chemistry ,Blood Proteins ,General Medicine ,General Chemistry ,Dendrimers | Hot Paper ,Combinatorial chemistry ,proteins ,0104 chemical sciences ,Liposomes ,Hydrophobic and Hydrophilic Interactions ,Blood stream ,Research Article ,Protein Binding ,Conjugate - Abstract
Amphiphilic surface groups play an important role in many biological processes. The synthesis of amphiphilic polyphenylene dendrimer branches (dendrons), providing alternating hydrophilic and lipophilic surface groups and one reactive ethynyl group at the core is reported. The amphiphilic surface groups serve as biorecognition units that bind to the surface of adenovirus 5 (Ad5), which is a common vector in gene therapy. The Ad5/dendron complexes showed high gene transduction efficiencies in coxsackie‐adenovirus receptor (CAR)‐negative cells. Moreover, the dendrons offer incorporation of new functions at the dendron core by in situ post‐modifications, even when bound to the Ad5 surface. Surfaces coated with these dendrons were analyzed for their blood‐protein binding capacity, which is essential to predict their performance in the blood stream. A new platform for introducing bioactive groups to the Ad5 surface without chemically modifying the virus particles is provided., Amphiphilic polyphenylene dendrons were prepared and bound to gene vector adenovirus 5 (Ad5) through polar and nonpolar surface groups that control its cellular uptake. The new dendron layer at the Ad5 surface provides reactive groups that are accessible for post‐modifications at the virus surface.
- Published
- 2020
39. [Fetal Alcohol Spectrum Disorders in Adults - Results from a Diagnostic Outpatient Clinic]
- Author
-
Tanja, Sappok, Marlene, Tergeist, Björn, Kruse, and Jessica, Wagner
- Subjects
Adult ,Alcohol Drinking ,Fetal Alcohol Spectrum Disorders ,Pregnancy ,Humans ,Female ,Ambulatory Care Facilities ,Delivery of Health Care - Abstract
Fetal alcohol spectrum disorders (FASD) are quite common and, due to the risk of psychiatric comorbidities, highly relevant until adulthood. Diagnostic clarification in adulthood is a prerequisite for targeted treatment and needs-based support. In a German metropolitan region, 80 people with suspicion of FASD were assessed from May 2015 to July 2020. The results of this interdisciplinary diagnostic assessment were systematically evaluated and the clinical characteristics of the persons with or without FASD were analysed.Approximately 70% of the population accessing relevant health care was diagnosed with an entity from the FAS spectrum. People with FASD were more likely to have learning disabilities (50 vs. 33%) or intellectual disabilities (40 vs. 10%), while there were no group differences for age and gender. Psychiatric comorbidities, particularly depression (39%) and addiction disorders (31%), were common in both groups.As part of a multi-professional standardized diagnosis, FASD clarification is also possible and necessary in adulthood. The diagnostic criteria for FASD should be further evaluated and specified for adults. Fetale Alkoholspektrum-Störungen sind nicht nur häufig, sie sind aufgrund des hohen Risikos für psychiatrische Komorbiditäten auch im Erwachsenenalter klinisch relevant. Die diagnostische Abklärung im Erwachsenenalter ist die Voraussetzung für eine zielgerichtete Behandlung und bedarfsgerechte Unterstützung. In einer Metropolenregion wurde zwischen Mai 2015 und Juli 2020 bei 80 Personen der Verdacht auf eine FASD diagnostisch abgeklärt. Die Ergebnisse dieser interdisziplinären Diagnostik wurden systematisch ausgewertet und die klinischen Charakteristika der Personen mit bzw. ohne FASD analysiert. Bei ca. 70% der Inanspruchnahmepopulation wurde eine Diagnose aus dem FAS-Spektrum gestellt. Personen mit FASD zeigten häufiger eine Lernbehinderung (50 vs. 33%) oder Intelligenzminderung (40 vs. 10%), während keine Gruppenunterschiede für Alter und Geschlecht bestanden. Psychiatrische Komorbiditäten, insbesondere Depressionen (39%) und Abhängigkeitserkrankungen (31%), waren in beiden Gruppen häufig. Im Rahmen einer multiprofessionellen standardisierten Diagnostik ist die FASD Abklärung auch im Erwachsenenalter möglich und nötig. Die Entwicklung standardisierter und spezifischer Diagnosekriterien für Erwachsene ist sinnvoll.
- Published
- 2022
40. B2B-Leads generieren und qualifizieren aus datenschutzrechtlicher Sicht
- Author
-
Clemens Thiele and Jessica Wagner
- Subjects
General Medicine - Published
- 2023
41. Nematicidal activity and in vitro radical scavenging from Piper cumbricola and Piper eriopodon
- Author
-
Ana María Mesa Vanegas, Jessica Wagner Arenas, Omar Ocampo Jiménez, O, and Zulma Monsalve Fonnegra, I
- Subjects
Bioengineering ,Agronomy and Crop Science ,Applied Microbiology and Biotechnology ,Food Science ,Biotechnology - Published
- 2023
42. DSB: Offener Zustellverteiler datenschutzwidrig
- Author
-
Jessica Wagner
- Subjects
General Medicine - Published
- 2023
43. BVwG: Veröffentlichung von Kontaktdaten des Lehrpersonals auf einer Schulwebsite
- Author
-
Jessica Wagner
- Subjects
General Medicine - Published
- 2023
44. 50 Years Ago in T J P
- Author
-
Jessica Wagner and Terrill Bravender
- Subjects
Pediatrics, Perinatology and Child Health - Published
- 2023
45. Pre-post Evaluation of the 'Supporting Student-Athlete Mental Wellness' Module for College Coaches
- Author
-
Brian Hainline, Emily Kroshus, Jessica Wagner, and David L. Wyrick
- Subjects
Medical education ,medicine.medical_specialty ,Referral ,Sports medicine ,Stigma (botany) ,030229 sport sciences ,Mental health ,Help-seeking ,03 medical and health sciences ,0302 clinical medicine ,Completion rate ,medicine ,030212 general & internal medicine ,Psychology ,Association (psychology) ,Mental health literacy ,Applied Psychology - Abstract
This study sought to determine whether completion of the National Collegiate Athletic Association’s “Supporting Student-Athlete Mental Wellness” online module for coaches increased mental health literacy, reduced stigma, and increased intentions to: 1) communicate proactively with team members about the importance of mental health care seeking, and 2) respond appropriately to support an athlete believed to be struggling with a mental health issue. College head coaches completed pre-test surveys (n = 969) and immediate post-test surveys (n = 347, completion rate = 36%). Module completion was associated with increased mental health literacy, decreased stigma about help seeking and increased intentions to engage in culture setting communication. These findings suggest that the online module is a good start for coach education about mental health; however, additional modifications may be warranted to the extent coach referral to sports medicine staff or provision of emotional support to student-athletes struggling with mental health concerns are considered desired behaviors.
- Published
- 2019
46. Actividad nematicida de especies del género Piper
- Author
-
Ana Maria MESA VANEGAS, Jessica WAGNER ARENAS, Omar OCAMPO JIMÉNEZ, and Zulma MONSALVE FONNEGRA
- Subjects
General Economics, Econometrics and Finance - Abstract
Los nematodos fitoparásitos son una de las principales causas de pérdidas económicas en la agricultura a nivel mundial. En los cultivos de Musa paradisiaca, los nematodos más abundantes y de mayor impacto son Radopholus similis, y Meloidogyne spp.
- Published
- 2022
47. Reversing Aβ Fibrillation and Inhibiting Aβ Primary Neuronal Cell Toxicity Using Amphiphilic Polyphenylene Dendrons
- Author
-
Siyuan Xiang, Jessica Wagner, Jana Hedrich, Tanja Weil, Klaus Müllen, David Y. W. Ng, and Thorsten Lückerath
- Subjects
Fibrillation ,Neurons ,Dendrimers ,Amyloid beta-Peptides ,Chemistry ,Endosome ,Polymers ,Cell ,Biomedical Engineering ,Pharmaceutical Science ,Fibril ,Biomaterials ,Mice ,medicine.anatomical_structure ,In vivo ,Alzheimer Disease ,Dendrimer ,Amphiphile ,medicine ,Biophysics ,Animals ,Neuron ,medicine.symptom - Abstract
Uncontrolled amyloid-beta (Aβ) fibrillation leads to the deposition of neurotoxic amyloid plaques and is associated with Alzheimer's disease. Inhibiting Aβ monomer fibrillation and dissociation of the formed fibers is regarded as a promising therapeutic strategy. Here, amphiphilic polyphenylene dendrons (APDs) are demonstrated to interrupt Aβ assembly and reduce Aβ-cell interactions. Containing alternating negatively charged sulfonic acid and hydrophobic n-propyl peripheral groups, APDs bind to the secondary structure of the Aβ aggregates, inhibiting fibrillation and disassemble the already formed Aβ fibrils. APDs reveal vesicular cellular uptake in endosomes as well as cell compatibility for endothelial and neuronal cells, and significantly reduce Aβ-induced neuron cytotoxicity in vitro. Moreover, they are transported into the brain and successfully cross the blood-brain barrier after systemic application in mice, indicating their high potential to inhibit Aβ fibrillation in vivo, which can be beneficial for developing therapeutic strategy for Alzheimer's disease.
- Published
- 2021
48. Sexually Transmitted Infection Transmission Dynamics During the Coronavirus Disease 2019 (COVID-19) Pandemic Among Urban Gay, Bisexual, and Other Men Who Have Sex With Men
- Author
-
Christina M Schumacher, Nicole Thornton, Jessica Wagner, Carla Tilchin, Khalil G Ghanem, Matthew M Hamill, Carl Latkin, Anne Rompalo, Sebastian Ruhs, Adena Greenbaum, and Jacky M Jennings
- Subjects
Microbiology (medical) ,Male ,Sexual and Gender Minorities ,Infectious Diseases ,Sexual Behavior ,Sexually Transmitted Diseases ,COVID-19 ,Humans ,HIV Infections ,Homosexuality, Male ,Pandemics - Abstract
Background The impact of coronavirus disease 2019 (COVID-19) mitigation measures on sexually transmitted infection (STI) transmission and racial disparities remains unknown. Our objectives were to compare sex and drug risk behaviors, access to sexual health services, and STI positivity overall and by race during the COVID-19 pandemic compared with pre-pandemic among urban sexual minority men (MSM). Methods Sexually active MSM aged 18–45 years were administered a behavioral survey and STI testing every 3-months. Participants who completed at least 1 during-pandemic (April 2020–December 2020) and 1 pre-pandemic study visit (before 13 March 2020) that occurred less than 6 months apart were included. Regression models were used to compare during- and pre-pandemic visit outcomes. Results Overall, among 231 MSM, reports of more than 3 sex partners declined(pandemic-1: adjusted prevalence ratio 0.68; 95% confidence interval: .54–.86; pandemic-2: 0.65, .51–.84; pandemic-3: 0.57, .43–.75), substance use decreased (pandemic-1: 0.75, .61–.75; pandemic-2: 0.62, .50–.78; pandemic-3: 0.61, .47–.80), and human immunodeficiency virus/preexposure prophylaxis care engagement (pandemic-1: 1.20, 1.07–1.34; pandemic-2: 1.24, 1.11–1.39; pandemic-3: 1.30, 1.16–1.47) increased. STI testing decreased (pandemic-1: 0.68, .57–.81; pandemic-2: 0.78, .67–.92), then rebounded (pandemic-3: 1.01, .87–1.18). Neither Chlamydia (pandemic-2: 1.62, .75–3.46; pandemic-3: 1.13, .24–1.27) nor gonorrhea (pandemic-2: 0.87, .46 1.62; pandemic-3: 0.56, .24–1.27) positivity significantly changed during vs pre-pandemic. Trends were mostly similar among Black vs. non-Black MSM. Conclusions We observed sustained decreases in STI risk behaviors but minimal change in STI positivity during compared with pre-pandemic. Our findings underscore the need for novel STI prevention strategies that can be delivered without in-person interactions.
- Published
- 2021
49. HIV Transmission Potential and Sex Partner Concurrency: Evidence for Racial Disparities in HIV Risk Among Gay and Bisexual Men (MSM)
- Author
-
Adena Greenbaum, Christina Schumacher, Errol L. Fields, Khalil G. Ghanem, Anne Rompalo, Matthew M. Hamill, Jessica Wagner, Carla Tilchin, Carl A. Latkin, and Jacky M. Jennings
- Subjects
Male ,Sexual network ,medicine.medical_specialty ,Social Psychology ,Sexual Behavior ,Human immunodeficiency virus (HIV) ,HIV Infections ,medicine.disease_cause ,Logistic regression ,Odds ,Sexual and Gender Minorities ,Medicine ,Humans ,Homosexuality, Male ,Hiv transmission ,business.industry ,Public health ,Public Health, Environmental and Occupational Health ,virus diseases ,Health psychology ,Infectious Diseases ,Sexual Partners ,Bisexuality ,business ,Serostatus ,Demography - Abstract
We determined whether racial disparities in HIV infection among gay and bisexual men (MSM) may be partially explained by racial differences in the HIV transmission potential (i.e. mixing of people living with HIV and people not living with HIV or of unknown HIV serostatus) and density (i.e. sex partner concurrency) of sexual networks. Data included a behavioral survey, testing for HIV, and an egocentric sexual network survey. Mixed effects logistic regressions were used for hypothesis testing. Black (vs. non-Black) MSM were more likely to not know their partner's HIV serostatus (21.8% vs. 9.6%). Similar proportions reported sex partner concurrency (67.1% vs. 68.0%). In adjusted analyses, among Black MSM, sex partner concurrency significantly increased the odds of an HIV transmission potential partnership (TPP), and this association was not significant among non-Black indexes. The association between an HIV TPP and sex partner concurrency may help explain persistent racial disparities in HIV prevalence.Determinamos si las disparidades raciales en infecciones del VIH entre hombres homosexuales y bisexuales (hombres que tienen sexo con hombres) puede ser parcialmente explicado por diferencias raciales en el potencial de transmisión del VIH (es decir, mezcla de personas viviendo con VIH y personas que no viven con VIH o cuyo estado serológico del VIH es desconocido) y densidad (es decir, concurrencia de pareja sexual) de redes sexuales. Los datos incluyeron una encuesta de comportamiento, pruebas para el VIH y una encuesta de redes sexuales egocéntrica. Regresiones logísticas de efectos mixtos fueron usados para la prueba de hipótesis. HSH negros (vs. HSH no-negros) eran más propensos a no saber el estado serológico del VIH de su pareja (21.8% vs. 9.6%). Proporciones similares reportaron concurrencia de pareja sexual (67.1% vs. 68.0%). En análisis ajustados, entre HSH negros, la concurrencia de pareja sexual aumentó significativamente las probabilidades de una asociación potencial de transmisión del VIH (TPP por sus siglas en inglés), y esta asociación no fue significativa entre índices de no-negros. La asociación entre una TPP VIH y concurrencia de pareja sexual puede ayudar a explicar disparidades raciales persistentes en la prevalencia del VIH.
- Published
- 2021
50. A Novel Orthotopic Implantation Technique for Osteosarcoma Produces Spontaneous Metastases and Illustrates Dose-Dependent Efficacy of B7-H3-CAR T Cells
- Author
-
Christopher DeRenzo, Lindsay J. Talbot, Stephen Gottschalk, Amy J. Funk, Aaron Ross, Heather Tillman, Ashley Chabot, Jessica Wagner, Phuong Nguyen, and Andrew M. Davidoff
- Subjects
0301 basic medicine ,B7 Antigens ,Lung Neoplasms ,medicine.medical_treatment ,Immunology ,Dose dependence ,Bone Neoplasms ,Immunotherapy, Adoptive ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Antigen ,Cell Line, Tumor ,medicine ,Immunology and Allergy ,Bioluminescence imaging ,Animals ,Humans ,Luciferase ,orthotopic ,Original Research ,Osteosarcoma ,Lung ,model ,Receptors, Chimeric Antigen ,Tibia ,business.industry ,Immunotherapy ,RC581-607 ,medicine.disease ,Xenograft Model Antitumor Assays ,CAR ,030104 developmental biology ,medicine.anatomical_structure ,Treatment Outcome ,B7-H3 ,030220 oncology & carcinogenesis ,T cell therapy ,Cancer research ,Female ,Car t cells ,Immunologic diseases. Allergy ,business - Abstract
The outcome for metastatic pediatric osteosarcoma (OS) remains poor. Thus, there is an urgent need to develop novel therapies, and immunotherapy with CAR T cells has the potential to meet this challenge. However, there is a lack of preclinical models that mimic salient features of human disease including reliable development of metastatic disease post orthotopic OS cell injection. To overcome this roadblock, and also enable real-time imaging of metastatic disease, we took advantage of LM7 OS cells expressing firefly luciferase (LM7.ffLuc). LM7.ffLuc were implanted in a collagen mesh into the tibia of mice, and mice reliably developed orthotopic tumors and lung metastases as judged by bioluminescence imaging and histopathological analysis. Intratibial implantation also enabled surgical removal by lower leg amputation and monitoring for metastases development post-surgery. We then used this model to evaluate the antitumor activity of CAR T cells targeting B7-H3, an antigen that is expressed in a broad range of solid tumors including OS. B7-H3-CAR T cells had potent antitumor activity in a dose-dependent manner and inhibited the development of pulmonary metastases resulting in a significant survival advantage. In contrast T cells expressing an inactive B7-H3-CAR had no antitumor activity. Using unmodified LM7 cells also enabled us to demonstrate that B7-H3-CAR T cells traffic to orthotopic tumor sites. Hence, we have developed an orthotopic, spontaneously metastasizing OS model. This model may improve our ability not only to predict the safety and efficacy of current and next generation CAR T cell therapies but also other treatment modalities for metastatic OS.
- Published
- 2021
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.